Chronic Microcystin-LR-Induced α-Synuclein Promotes Neuroinflammation Through Activation of the NLRP3 Inflammasome in...

Area of Science:

• Neuroscience
• Toxicology
• Immunology

Background:

• Microcystin-LR (MC-LR) crosses the blood-brain barrier, causing neurotoxicity.
• The precise mechanisms of MC-LR neurotoxicity and its link to neurodegenerative diseases remain unclear.
• Alpha-synuclein (α-syn) aggregation is a hallmark of Parkinson's disease (PD).

Purpose of the Study:

• To elucidate the neurotoxic mechanisms of MC-LR.
• To investigate the role of MC-LR in α-synuclein (α-syn) pathology and neuroinflammation.
• To determine the involvement of microglia and specific signaling pathways in MC-LR-induced neurotoxicity.

Main Methods:

• In vitro studies using neuronal and microglial cell lines (HMC3).
• In vivo experiments using mouse models of chronic MC-LR exposure.
• Analysis of ubiquitin-proteasome system function, α-synuclein levels, microglial activation (M1 polarization), TLR4 receptor expression, and NLRP3 inflammasome activation.
• Measurement of inflammatory cytokines (IL-6, IL-1β, TNF-α, IL-18).

Main Results:

• MC-LR disrupted the neuronal ubiquitin-proteasome system, inhibiting α-synuclein degradation.
• MC-LR induced α-synuclein release from neurons, uptake by microglia via TLR4, and subsequent M1 polarization.
• Activated microglia released IL-18 and IL-1β through NLRP3 inflammasome activation.
• Chronic MC-LR exposure in mice led to increased brain inflammatory factors and microglial NLRP3 activation.

Conclusions:

• MC-LR promotes α-synuclein cell-to-cell spread and triggers neuroinflammation via microglial NLRP3 inflammasome activation.
• The TLR4 receptor plays a critical role in MC-LR-induced microglial activation and inflammatory responses.
• These findings suggest MC-LR as a potential environmental risk factor contributing to Parkinson's disease-like pathology.